FDA Food and Drug Administration

Order byBest matchMost fresh

FDA panel is split on updates to COVID shots

FDA picks a new strain for fall Covid vaccines. Here's what it means for your next shot.

The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most at-risk Americans this fall.

· 2h · on MSN

STAT · 4h

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

· 23h · on MSN

FDA panel is split on updates to COVID shots as questions loom for fall vaccinations

FDA panel recommends keeping COVID shots targeted to same strain as last year

Advisers to the Food and Drug Administration have recommended COVID-19 vaccine makers continue to target their shots to the so-called JN.1 coronavirus strain for the upcoming fall and winter seasons, ...

· 1d

FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules

wtvr · 23h

FDA advisory committee meets on COVID-19 vaccine after putting new restrictions on approvals

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 1d

· 5h

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

· 1d

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

FDA, allergy and the itching

Digest more

Feeling itchy? FDA warns about rare side effect from some allergy drugs

Both medicines are available over-the-counter or through a prescription.

· 9h · on MSN

WCPO 9 News · 1h

Stopping these popular allergy medications could lead to severe itching, FDA warns

· 1d · on MSN

FDA issues warning about allergy medications

FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound).

4hon MSN

GSK's asthma drug wins FDA approval to treat 'smoker's lung'

The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic lung disease commonly known as "smoker's lung", the company said on Thursday.

STAT1d

FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’

The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of other FDA issues currently in the political spotlight. The FDA’s budget was not mentioned in the president’s preliminary spending package,

Trump FDA Reveals Canada Will Play Major Role In Bringing Drug Prices Down

The Food and Drug Administration (FDA) announced Wednesday plans to help states and Indian tribes import cheaper prescription drugs from Canada. The initiative is in support of President Donald Trump’s executive order on May 12 which promised to deliver “most-favored nation prescription drug pricing” to America,

Trump administration proposes cutting FDA budget by 5.5%

The Trump administration is proposing a $6.8 billion budget request for the U.S. Food and Drug Administration for the 2026 fiscal year, Commissioner of Food and Drugs Martin Makary said on Thursday.

2don MSN

FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in the United States have come to rely on.

FDA Commissioner Makary Cites Real Clear Journal Article At Panel On Talc In The American Food Supply

"Expert Panels with the FDA" are a series of roundtable discussions to provide an open public discourse on the latest medical and scientific information on several important topics. At this roundtable,

2don MSN

Food and Drug Administration lays out new requirements for annual COVID-19 vaccines

Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults with certain health conditions that puts them at risk will be approved for the shot.